Exosomes derived from miR-122-modified adipose tissue-derived MSCs increase chemosensitivity of hepatocellular carcinoma.
Lou G, Song X, Yang F, Wu S, Wang J, Chen Z, Liu Y. · 2015
Read Exosomes derived from miR-122-modified adipose tissue-derived MSCs increase chemosensitivity of hepatocellular carcinoma. by Lou G, Song X, Yang F, Wu S, Wang J, Chen Z, Liu Y. (2015) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4627430.txt.
Description
A 2015 study using tiny cell-made packets to deliver a liver-protecting RNA into liver cancer cells came from Guohua Lou and colleagues. Hepatocellular carcinoma resists chemotherapy strongly. A small RNA called miR-122 can restore drug sensitivity, but getting it into tumours is hard. The team loaded it into exosomes shed by fat tissue stem cells. The work appeared in the Journal of Experimental and Clinical Cancer Research.
Stem cells engineered to make extra miR-122 packed it into their exosomes. Cancer cells taking up those packets changed their gene activity and became sensitive to chemotherapy drugs again. In mice, injecting the loaded exosomes into tumours boosted the effect of the drug sorafenib. The study supports exosomes as natural delivery vehicles for RNA-based cancer treatment.
Catalog record
| CREATOR | Lou G, Song X, Yang F, Wu S, Wang J, Chen Z, Liu Y. |
|---|---|
| YEAR | 2015 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 35 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |